Both blood tests seem to be important tests, but one tests the potential aggressiveness of prostate cancer while the other one tests for 50 different types of cancer at a very early stage.

The 4K score blood test is primarily used for detecting prostate cancer and is an important medical contribution. It measures four prostate specific biomarkers in the blood, along with clinical factors such as age, digital rectal exam, and can but not usually, include prior prostate biopsy results. The test helps determine the probability of finding high-grade prostate cancer on biopsy in men who usually have not yet had a biopsy.

On the other hand, the Galleri blood test is designed to detect many different types of cancer in the body. It utilizes next generation sequencing to search for DNA alterations in blood circulation (hence the cancer cell shedding concept) that are typically associated with various types of cancer. The test can detect cancer even in asymptomatic individuals and is particularly useful for detecting cancer at an early stage. That’s a big deal and making it part of all blood tests at an early age might help minimize cancer struggles, pain and advanced cancer solutions not to mention perhaps even death. One hopes.